PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre régional de Pharmacovigilance, Hôpital François Mitterrand, 14 Rue Paul Gaffarel, BP77908, Dijon, 21079, France. aurelie.grandvuillemin@chu-dijon.fr.\', \'Regional Pharmacovigilance Center of Nice, Department of Clinical Pharmacology, Université Côte d\'Azur, Nice, France.\', \'Regional Pharmacovigilance Center of Tours, Service de Pharmacosurveillance, CHRU, Tours, France.\', \'Regional Pharmacovigilance Center of Marseille, Service Hospitalo-Universitaire de Pharmacologie Clinique et Pharmacovigilance, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Institut des Neurosciences des Systèmes, INSERM 1106, Marseille, France.\', \'Regional Center of Pharmacovigilance, Pharmacoepidemiology and Drug Information, Service de Pharmacologie Médicale et Clinique, IC 1436 INSERM, Faculty of Medicine, University Hospital, Toulouse, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40264-020-01034-y
?:hasPublicationType
?:journal
  • Drug safety
is ?:pmid of
?:pmid
?:pmid
  • 33372244
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.447
?:rankingScore_hIndex
  • 112
?:title
  • French Pharmacovigilance Public System and COVID-19 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33372244>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33372244>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all